Early Patient Access Single Named Patient Program for the Use of Ulocuplumab for the Treatment of Multiple Myeloma
Clinical trial NCT02666209 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT02666209
- Sponsor
- Dana-Farber Cancer Institute
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.